Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › San Diego › NPI 1659352276
Lab

Laboratory Corporation of America

Laboratory Corporation of America was paid $147.14M by Medicaid between Jan 2018 and Dec 2024, across 647 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 14% of everything it billed.

33Billing provider infoLABORATORY CORPORATION OF AMERICA
SAN DIEGO, CA 92128
33aNPI1659352276assigned 11/10/2005
33bProvider typeClinical Medical Laboratory
28Total paid$147.14M
24GClaims64,360,026
24DCodes billed647
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#6 of 561
Median peer was paid$222K
This provider vs. median663×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$2.0M$4.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20187,112,307$15.58M
20198,148,029$13.58M
20207,658,109$15.54M
20219,331,645$30.33M
20229,906,183$25.51M
202310,678,851$22.54M
2024incomplete11,524,902$24.07M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 14% 697,953 637,981 $20.02M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 5.8% 1,523,257 1,472,245 $8.48M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 5.4% 1,482,243 1,432,612 $7.97M
84443 Thyroid stimulating hormone (TSH) 4.2% 3,346,151 3,289,741 $6.15M
80053 Comprehensive metabolic panel 4.1% 4,672,206 4,499,454 $5.96M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 4.0% 2,025,994 2,003,149 $5.95M
80061 Lipid panel 3.8% 3,751,397 3,709,555 $5.66M
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel 3.0% 28,628 28,488 $4.44M
80081 3.0% 83,408 75,885 $4.41M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.8% 4,591,744 4,392,966 $4.11M
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants 2.7% 55,192 54,222 $3.96M
83036 Hemoglobin; glycosylated (A1C) 2.7% 3,430,686 3,384,377 $3.91M
635 more codes
86480 2.4% 238,141 $3.60M
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 2.1% 957,271 $3.12M
87536 1.6% 86,179 $2.43M
88305 Level IV - Surgical pathology, gross and microscopic examination 1.2% 96,048 $1.74M
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 1.1% 498,835 $1.66M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.1% 301,189 $1.63M
87086 Culture, bacterial; quantitative colony count, urine 1.1% 1,080,965 $1.57M
86803 <1% 536,258 $1.47M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 286,342 $1.40M
80074 <1% 268,887 $1.30M
84439 <1% 1,289,533 $1.26M
86003 <1% 147,878 $1.21M
86235 <1% 88,259 $1.08M
82746 <1% 553,680 $1.01M
86592 <1% 1,126,613 $992K
83655 <1% 358,004 $906K
82607 <1% 677,536 $861K
84403 <1% 228,209 $814K
84153 <1% 360,871 $786K
87901 <1% 4,723 $711K
82728 <1% 406,959 $692K
82274 <1% 349,867 $679K
87186 <1% 382,171 $609K
87522 Neg quan hep c or qual rna <1% 55,026 $596K
85027 <1% 538,024 $590K
88185 <1% 3,550 $585K
87902 <1% 7,872 $551K
84702 <1% 231,820 $536K
81329 <1% 31,494 $534K
86361 <1% 54,872 $530K
83970 <1% 117,288 $518K
87900 <1% 7,705 $511K
87340 <1% 392,971 $494K
81001 <1% 1,011,144 $493K
86769 <1% 33,042 $491K
82043 <1% 823,007 $488K
87088 <1% 398,347 $482K
82570 <1% 731,872 $456K
83550 <1% 421,995 $434K
87150 <1% 79,801 $420K
82670 <1% 123,170 $417K
84402 <1% 107,561 $416K
83013 <1% 84,022 $412K
83540 <1% 470,368 $410K
86360 <1% 22,968 $402K
84481 <1% 200,747 $373K
86038 <1% 253,125 $366K
87081 <1% 264,218 $362K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 263,881 $354K
86787 <1% 105,613 $348K
81490 <1% 4,407 $346K
81229 <1% 2,083 $340K
83880 <1% 59,294 $338K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 16,226 $336K
87077 <1% 223,215 $327K
80048 Basic metabolic panel (calcium, ionized) <1% 343,122 $325K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 296,426 $318K
86706 <1% 177,152 $303K
83001 <1% 169,005 $299K
86696 <1% 121,706 $288K
82951 <1% 89,956 $282K
87906 <1% 4,369 $275K
86780 <1% 77,127 $271K
87070 <1% 176,309 $270K
86704 <1% 130,842 $267K
86762 <1% 200,607 $263K
86376 <1% 139,462 $252K
82105 <1% 57,547 $251K
82652 <1% 62,867 $250K
83002 <1% 148,351 $249K
81374 <1% 15,280 $248K
84146 <1% 136,204 $244K
83735 <1% 240,942 $232K
84550 <1% 416,354 $227K
86140 <1% 356,050 $225K
84436 <1% 416,208 $215K
84480 <1% 171,908 $215K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 354,867 $210K
86708 <1% 79,539 $201K
80050 General health panel <1% 22,829 $189K
88341 <1% 5,989 $189K
86695 <1% 110,532 $185K
86300 <1% 29,184 $183K
86225 <1% 103,868 $181K
82950 <1% 163,217 $180K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed <1% 11,996 $177K
99199 Unlisted special service, procedure or report <1% 48,663 $173K
82627 <1% 50,105 $162K
86160 <1% 74,635 $159K
82533 <1% 45,296 $159K
88313 <1% 12,184 $157K
86147 <1% 23,461 $156K
82378 <1% 56,349 $156K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 265,999 $153K
85652 <1% 480,239 $150K
86800 <1% 69,442 $148K
81401 <1% 3,054 $147K
88342 <1% 7,242 $146K
86431 <1% 210,941 $144K
84144 <1% 54,668 $144K
85610 <1% 327,719 $140K
80076 <1% 242,503 $139K
36415 Collection of venous blood by venipuncture <1% 4,333,084 $135K
84154 <1% 70,235 $132K
84100 <1% 177,743 $131K
82784 <1% 89,186 $128K
86317 <1% 55,305 $123K
80197 <1% 37,455 $123K
82248 <1% 89,316 $121K
83516 <1% 67,311 $121K
84445 <1% 17,250 $119K
86765 <1% 62,234 $118K
81003 <1% 1,182,164 $117K
85730 <1% 225,855 $117K
83525 <1% 100,630 $112K
86200 <1% 97,203 $111K
84479 <1% 225,420 $111K
82785 <1% 103,451 $111K
86735 <1% 60,218 $110K
87209 <1% 52,790 $110K
82977 <1% 103,958 $101K
82024 <1% 14,561 $100K
81243 <1% 8,874 $99K
80055 <1% 4,554 $99K
87517 <1% 14,052 $99K
84450 <1% 155,903 $98K
87799 <1% 10,089 $98K
88189 <1% 3,095 $97K
82565 <1% 156,785 $91K
83690 <1% 91,954 $90K
86141 <1% 45,737 $89K
83520 <1% 42,241 $85K
82397 <1% 19,424 $85K
82947 <1% 208,619 $83K
86665 <1% 18,728 $82K
84460 <1% 123,263 $82K
83498 <1% 18,907 $79K
80164 <1% 30,200 $78K
81162 <1% 556 $78K
83521 <1% 9,247 $77K
88312 <1% 31,104 $77K
88262 <1% 2,755 $77K
86359 <1% 7,400 $77K
86677 <1% 27,541 $77K
80069 <1% 58,450 $74K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 22,853 $74K
85045 <1% 96,349 $74K
83615 <1% 110,851 $73K
82247 <1% 115,673 $71K
86593 <1% 33,484 $71K
81206 <1% 2,685 $70K
84156 <1% 158,021 $70K
81479 Unlisted molecular pathology procedure <1% 1,117 $69K
84681 <1% 29,711 $65K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 42,337 $65K
84425 <1% 27,933 $65K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 775 $63K
82040 <1% 92,322 $63K
87480 <1% 20,370 $63K
84270 <1% 13,833 $62K
80299 <1% 6,891 $61K
87660 <1% 20,339 $61K
87510 <1% 20,328 $60K
81270 <1% 2,953 $59K
83003 <1% 4,236 $58K
82150 <1% 71,294 $57K
88184 <1% 3,507 $57K
87177 <1% 53,146 $57K
86341 <1% 8,855 $55K
82550 <1% 75,616 $55K
81207 <1% 2,684 $54K
87535 <1% 11,034 $54K
84520 <1% 117,288 $53K
84075 <1% 90,510 $53K
87075 <1% 24,853 $53K
81257 <1% 1,411 $52K
84305 <1% 20,218 $51K
84466 <1% 18,728 $51K
84165 <1% 33,558 $50K
86381 <1% 13,256 $50K
83695 <1% 18,928 $50K
82310 <1% 93,334 $49K
86301 <1% 16,116 $49K
86146 <1% 14,714 $49K
87497 <1% 6,404 $49K
86709 <1% 32,506 $49K
86364 <1% 31,794 $48K
84410 <1% 2,951 $48K
88112 <1% 5,119 $47K
86635 <1% 11,877 $46K
86304 <1% 26,555 $45K
86850 <1% 167,077 $44K
82672 <1% 20,095 $44K
86334 <1% 15,268 $43K
87427 <1% 43,524 $42K
87045 <1% 43,692 $41K
88230 <1% 2,815 $41K
84207 <1% 18,963 $40K
84155 <1% 103,606 $40K
82107 <1% 7,525 $39K
86901 <1% 180,806 $39K
86664 <1% 12,404 $38K
86355 <1% 2,662 $37K
81381 <1% 816 $37K
86256 <1% 12,775 $37K
82952 <1% 37,609 $37K
86702 <1% 11,150 $37K
80159 <1% 8,643 $37K
87538 <1% 10,110 $36K
86900 <1% 179,735 $36K
83921 <1% 14,115 $36K
84295 <1% 67,416 $35K
83721 <1% 28,335 $35K
85018 <1% 159,685 $35K
84432 <1% 10,290 $33K
82239 <1% 9,348 $33K
85060 <1% 17,910 $33K
82542 <1% 5,131 $33K
82088 <1% 5,861 $32K
86008 <1% 7,371 $31K
80178 <1% 17,294 $31K
85014 <1% 91,593 $31K
80230 <1% 2,160 $31K
86337 <1% 5,791 $30K
82626 <1% 13,232 $30K
82435 <1% 63,990 $29K
83090 <1% 19,434 $29K
83021 <1% 11,490 $29K
82330 <1% 18,079 $29K
82166 <1% 4,021 $28K
82140 <1% 14,554 $28K
84152 <1% 2,970 $28K
86701 <1% 9,800 $28K
83883 <1% 22,196 $28K
80051 <1% 34,565 $27K
82103 <1% 17,209 $27K
84132 <1% 70,353 $27K
82172 <1% 18,716 $25K
86015 <1% 13,785 $25K
84140 <1% 2,325 $25K
86705 <1% 20,617 $24K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 3,295 $24K
82390 <1% 17,892 $24K
87529 <1% 39,165 $24K
81403 <1% 401 $23K
84134 <1% 22,947 $23K
84630 <1% 18,712 $23K
83020 <1% 15,147 $22K
86037 <1% 7,058 $22K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 3,433 $22K
88173 <1% 2,165 $22K
84482 <1% 7,366 $22K
81596 <1% 5,309 $21K
87210 <1% 14,458 $21K
81256 <1% 1,679 $21K
87507 <1% 2,536 $21K
83010 <1% 19,746 $20K
87521 Neg quan hep c or qual rna <1% 2,891 $20K
82668 <1% 6,880 $20K
86258 <1% 9,940 $20K
87338 <1% 75,475 $19K
82465 <1% 66,789 $19K
82157 <1% 4,200 $19K
84999 <1% 657 $18K
83014 <1% 39,351 $18K
84703 <1% 70,115 $18K
86694 <1% 8,692 $18K
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 5,810 $18K
85245 <1% 8,559 $18K
84244 <1% 5,892 $17K
85246 <1% 9,181 $17K
86870 <1% 1,778 $17K
84478 <1% 41,009 $17K
87625 <1% 1,523 $16K
85379 <1% 11,296 $16K
86618 <1% 4,586 $16K
81500 <1% 944 $16K
82610 <1% 8,667 $16K
80202 <1% 7,456 $16K
87046 <1% 43,576 $16K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 952 $16K
85240 <1% 9,491 $15K
81422 <1% 2,178 $15K
86644 <1% 6,550 $15K
81241 <1% 1,743 $15K
82985 <1% 4,311 $15K
80177 <1% 10,636 $15K
87350 <1% 11,993 $15K
86162 <1% 5,821 $15K
86777 <1% 4,471 $14K
86335 <1% 3,699 $14K
83993 <1% 17,309 $14K
87324 <1% 15,055 $14K
82525 <1% 10,619 $14K
88141 <1% 59,249 $14K
87184 <1% 3,734 $13K
86663 <1% 5,140 $13K
84080 <1% 5,284 $13K
87255 <1% 4,238 $13K
84590 <1% 12,560 $13K
80145 <1% 792 $13K
86255 <1% 19,759 $12K
87563 <1% 22,714 $12K
87329 <1% 10,959 $12K
82787 <1% 3,479 $12K
85598 <1% 9,233 $12K
85007 <1% 18,114 $12K
86645 <1% 5,130 $12K
82679 <1% 3,173 $11K
88304 <1% 12,848 $11K
81517 <1% 272 $11K
81025 <1% 20,747 $11K
88142 <1% 35,553 $10K
84166 <1% 8,348 $10K
86357 <1% 1,520 $10K
83527 <1% 1,855 $10K
86790 <1% 1,765 $10K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 3,357 $10K
85041 <1% 34,102 $10K
85048 <1% 33,932 $9K
82552 <1% 2,318 $9K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 2,703 $9K
82681 <1% 1,603 $9K
80185 <1% 5,029 $9K
82232 <1% 4,284 $9K
83519 <1% 3,778 $9K
85613 <1% 15,047 $9K
83718 <1% 12,794 $8K
84120 <1% 895 $8K
80156 <1% 4,792 $8K
87493 <1% 2,445 $8K
87040 <1% 4,304 $8K
87205 <1% 9,791 $8K
86060 <1% 18,114 $8K
88360 <1% 264 $7K
82374 <1% 5,709 $7K
82104 <1% 3,980 $7K
84484 <1% 4,658 $7K
88344 <1% 315 $7K
85004 <1% 4,176 $7K
86707 <1% 7,809 $7K
82642 <1% 630 $7K
82955 <1% 3,017 $7K
85660 <1% 13,108 $6K
80175 <1% 4,937 $6K
86671 <1% 6,858 $6K
80158 <1% 1,316 $6K
82164 <1% 4,256 $6K
87076 <1% 4,272 $6K
87101 <1% 11,968 $6K
84378 <1% 9,980 $6K
86308 <1% 9,194 $6K
82553 <1% 4,087 $6K
82085 <1% 10,961 $6K
G0475 Hiv antigen/antibody, combination assay, screening <1% 1,193 $6K
80165 <1% 3,168 $6K
81402 <1% 240 $6K
81240 <1% 933 $6K
87467 <1% 351 $6K
84446 <1% 5,539 $5K
86036 <1% 3,404 $5K
82747 <1% 5,808 $5K
86617 <1% 1,428 $5K
84143 <1% 860 $5K
80162 <1% 2,550 $5K
87116 <1% 2,140 $5K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,983 $5K
82575 <1% 4,310 $5K
86356 <1% 941 $5K
86747 <1% 1,280 $5K
87206 <1% 6,490 $5K
83835 <1% 4,484 $5K
82340 <1% 5,932 $5K
84433 <1% 405 $4K
81377 <1% 243 $4K
86231 <1% 17,741 $4K
82657 <1% 969 $4K
85597 <1% 3,872 $4K
82523 <1% 780 $4K
85670 <1% 11,352 $4K
81260 <1% 500 $4K
80184 <1% 2,472 $4K
82507 <1% 1,501 $4K
86171 <1% 2,611 $3K
86778 <1% 2,041 $3K
81291 <1% 704 $3K
85306 <1% 2,457 $3K
87015 <1% 820 $3K
85384 <1% 4,265 $3K
89055 <1% 7,821 $3K
83704 <1% 2,854 $3K
80195 <1% 1,412 $3K
83935 <1% 3,652 $3K
82030 <1% 176 $3K
84145 <1% 838 $3K
84255 <1% 3,403 $3K
81251 <1% 456 $3K
81200 <1% 499 $3K
81330 <1% 456 $3K
84300 <1% 4,206 $3K
81255 <1% 438 $2K
83789 <1% 2,078 $2K
82653 <1% 4,267 $2K
83625 <1% 1,771 $2K
84597 <1% 2,008 $2K
87481 <1% 10,250 $2K
81290 <1% 442 $2K
81242 <1% 443 $2K
S5102 Adult day care, billed per day <1% 25 $2K
83930 <1% 2,516 $2K
87807 <1% 634 $2K
86710 <1% 247 $2K
81015 <1% 2,054 $2K
84252 <1% 3,734 $2K
85049 <1% 4,550 $2K
80183 <1% 1,883 $2K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 1,488 $2K
87328 <1% 3,231 $2K
81599 <1% 864 $2K
82530 <1% 2,000 $2K
80201 <1% 1,520 $2K
83951 <1% 173 $2K
85300 <1% 1,826 $2K
83825 <1% 1,401 $2K
83945 <1% 1,509 $2K
86682 <1% 411 $2K
85732 <1% 13,388 $2K
83605 <1% 953 $2K
85303 <1% 1,549 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 10,109 $1K
87650 <1% 145 $1K
89051 <1% 1,228 $1K
81209 <1% 441 $1K
87106 <1% 2,222 $1K
86880 <1% 3,099 $1K
82175 <1% 976 $1K
80180 <1% 206 $1K
85705 <1% 1,313 $1K
86738 <1% 237 $1K
82308 <1% 1,072 $1K
84238 <1% 154 $1K
86606 <1% 1,119 $1K
84560 <1% 2,052 $1K
80280 <1% 65 $1K
84133 <1% 1,920 $1K
88289 <1% 318 $1K
81361 <1% 309 $994.90
80361 <1% 55,458 $986.95
86316 <1% 1,613 $921.58
80347 <1% 51,075 $814.50
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 119 $744.20
82677 <1% 541 $740.63
86148 <1% 421 $708.73
88271 <1% 58 $691.13
87420 <1% 416 $685.06
80375 <1% 25 $681.91
88275 <1% 40 $678.29
85302 <1% 1,179 $662.73
86631 <1% 2,753 $628.29
84105 <1% 1,020 $610.14
87899 <1% 416 $610.07
82436 <1% 888 $606.36
80348 <1% 54,904 $600.50
89060 <1% 479 $593.55
85305 <1% 1,322 $588.79
84591 <1% 2,249 $583.91
80365 <1% 52,315 $565.96
86366 <1% 30 $543.24
82384 <1% 1,335 $540.20
87486 <1% 437 $526.00
80373 <1% 51,066 $519.24
80358 <1% 50,758 $515.92
80354 <1% 54,236 $509.49
80353 <1% 50,638 $509.10
86340 <1% 348 $508.93
80359 <1% 51,393 $502.44
80372 <1% 50,578 $490.89
82180 <1% 562 $463.59
86005 <1% 13,884 $448.87
83874 <1% 201 $442.30
82705 <1% 2,552 $419.62
86615 <1% 306 $418.94
83986 <1% 2,066 $416.74
86022 <1% 198 $391.00
87102 <1% 1,776 $370.70
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,232 $365.89
82941 <1% 607 $360.74
87252 <1% 206 $359.12
80324 <1% 13,886 $327.04
87631 <1% 492 $322.38
83631 <1% 936 $308.97
84206 <1% 281 $295.25
84392 <1% 653 $290.48
84540 <1% 404 $282.41
82540 <1% 462 $274.02
84150 <1% 15 $262.16
83992 <1% 40,969 $260.04
86658 <1% 226 $259.17
80349 <1% 4,137 $251.81
86161 <1% 390 $239.91
82656 <1% 1,333 $237.28
81364 <1% 38 $233.69
81219 <1% 13 $225.03
83529 <1% 28 $207.18
86305 <1% 98 $197.64
86336 <1% 253 $196.70
82615 <1% 271 $193.28
81383 <1% 89 $184.31
87109 <1% 681 $178.44
86632 <1% 1,954 $174.03
86331 <1% 1,188 $173.73
82634 <1% 13 $168.73
82379 <1% 385 $164.29
87425 <1% 370 $153.00
80370 <1% 40,990 $147.63
80368 <1% 42,294 $146.25
80171 <1% 30 $144.59
80326 <1% 39,171 $142.72
P9011 Blood, split unit <1% 60 $142.17
80377 <1% 39,115 $141.26
80360 <1% 41,142 $139.86
80366 <1% 39,397 $139.69
80367 <1% 39,338 $139.27
80355 <1% 39,571 $138.51
82300 <1% 42 $136.46
80341 <1% 39,097 $136.02
80364 <1% 39,090 $135.85
85247 <1% 247 $135.54
80337 <1% 40,825 $135.03
80331 <1% 39,086 $132.92
80334 <1% 40,441 $131.79
80344 <1% 39,099 $131.79
80338 <1% 40,873 $131.45
80371 <1% 39,093 $131.28
87496 <1% 12 $125.38
80357 <1% 39,699 $122.85
85301 <1% 490 $108.17
84442 <1% 59 $107.87
86001 <1% 1,635 $102.55
80356 <1% 1,950 $101.65
80220 <1% 90 $101.35
G0307 Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) <1% 40 $100.04
83919 <1% 153 $99.15
G0306 Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count <1% 54 $95.77
86609 <1% 94 $91.16
86692 <1% 47 $86.78
81244 <1% 65 $85.32
87254 <1% 732 $79.31
81050 <1% 284 $68.86
36416 <1% 2,610 $68.72
86215 <1% 24 $67.55
85385 <1% 712 $64.14
87581 <1% 436 $63.00
86804 <1% 15 $61.16
82139 <1% 622 $60.01
86611 <1% 215 $59.70
84202 <1% 98 $57.43
83497 <1% 44 $56.99
80235 <1% 172 $49.23
82010 <1% 13 $46.55
80179 <1% 39 $45.63
87905 <1% 828 $43.20
86602 <1% 52 $40.10
82595 <1% 91 $37.57
80203 <1% 218 $32.03
82365 <1% 732 $27.52
80362 <1% 2,887 $25.96
86157 <1% 40 $24.25
85307 <1% 12 $22.90
81002 <1% 13 $22.69
82131 <1% 223 $18.36
89321 <1% 29 $16.41
83876 <1% 247 $14.98
80321 <1% 672 $13.76
84163 <1% 24 $13.65
82360 <1% 361 $12.58
86703 <1% 857 $12.51
86698 <1% 80 $9.76
99000 <1% 2,135 $3.63
82945 <1% 12 $3.29
82270 <1% 27 $2.92
80500 0% 917 $0.00
80342 0% 180 $0.00
88302 0% 309 $0.00
80346 0% 3,368 $0.00
88321 0% 1,166 $0.00
80503 0% 310 $0.00
88164 0% 8,566 $0.00
0097U 0% 397 $0.00
86596 0% 42 $0.00
86042 0% 28 $0.00
88147 0% 2,486 $0.00
99001 0% 3,144 $0.00
80323 0% 500 $0.00
85250 0% 65 $0.00
80332 0% 14 $0.00
85549 0% 13 $0.00
86362 0% 12 $0.00
83080 0% 34 $0.00
87275 0% 37 $0.00
87299 0% 37 $0.00
86051 0% 30 $0.00
84588 0% 13 $0.00
81335 0% 17 $0.00
87260 0% 37 $0.00
0024U 0% 29 $0.00
87279 0% 37 $0.00
89310 0% 14 $0.00
80169 0% 12 $0.00
80168 0% 12 $0.00
88346 0% 12 $0.00
86043 0% 29 $0.00
88237 0% 12 $0.00
82375 0% 12 $0.00
83698 0% 14 $0.00
80345 0% 37 $0.00
96040 0% 274 $0.00
88307 0% 214 $0.00
80374 0% 1,354 $0.00
87593 0% 144 $0.00
88311 0% 31 $0.00
80320 0% 216 $0.00
86041 0% 70 $0.00
G0145 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision 0% 39 $0.00
85362 0% 37 $0.00
87280 0% 38 $0.00
84260 0% 50 $0.00
80186 0% 14 $0.00
82017 0% 39 $0.00
85415 0% 19 $0.00
87276 0% 37 $0.00
87505 0% 12 $0.00
87337 0% 12 $0.00
84181 0% 34 $0.00
88300 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWILLIAMS, KIMBERLY (VP)
Same official

Other billing entities under WILLIAMS, KIMBERLY

Full network →
ProviderLocationPaid
Laboratory Corporation of America HoldingsBurlington, NC$1.44B
Laboratory Corporation of America HoldingsRaritan, NJ$717.47M
Laboratory Corporation of America HoldingsDublin, OH$617.02M
Laboratory Corporation of America HoldingsBirmingham, AL$289.12M
Laboratory Corporation of AmericaPhoenix, AZ$265.90M
Laboratory Corporation of America HoldingsBurlington, NC$264.26M
Laboratory Corporation of America HoldingsCharleston, WV$220.04M
Laboratory Corporation of AmericaSeattle, WA$186.69M
Laboratory Corporation of AmericaTampa, FL$171.13M
Laboratory Corporation of AmericaHouston, TX$103.81M
Laboratory Corporation of AmericaEnglewood, CO$77.80M
Laboratory Corporation of AmericaDallas, TX$77.42M
Laboratory Corporation of AmericaBurlington, NC$59.75M
Medtox Laboratories, INCSaint Paul, MN$47.72M
Laboratory Corporation of America HoldingsBurlington, NC$15.65M
Laboratory Corporation of AmericaSan Antonio, TX$11.67M
Tri-Cities Laboratory, LLCKennewick, WA$8.69M
Laboratory Corporation of America HoldingsMonroe, LA$3.39M
Laboratory Corporation of AmericaItasca, IL$3.37M
Laboratory Corporation of AmericaAlbany, NY$2.06M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.